ReviewInternational journal of molecular sciences2026
DeepSnap: From Three-Dimensional Molecular Images to Quantitative Structure-Activity Predictions.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Quantitative structure-activity relationship (QSAR) modeling has conventionally relied on expert-designed molecular descriptors to encode chemical structures. DeepSnap is a descriptor-free QSAR approach that converts prepared three-dimensional molecular conformers into image representations and feeds them directly into convolutional neural networks for activity prediction. This focused narrative review traces DeepSnap from its introduction in 2018 to its current state and places it within the broader landscape of descriptor-based QSAR, topology-based and 3D-aware graph neural networks, and related image-based or semi-image-based molecular representation approaches. Previous studies applied DeepSnap to Tox21 nuclear receptor and molecular initiating event endpoints, rat hepatic clearance, blood-brain barrier penetration, acute oral toxicity, and cosmetics-pharmaceutical compound classification. Across the DeepSnap series, image-based and descriptor-based predictions have provided complementary information, particularly in ensemble or consensus models. However, high or near-ceiling ROC-AUC values reported for selected endpoints should not be interpreted as indicating deterministic or universally generalizable predictions; rather, they should be considered in the context of endpoint-specific model development, image-rendering parameter optimization, possible class imbalance, split dependence, limited matched external replication, and incomplete benchmarking against modern molecular representation models. Limitations include a dependence on nonphysical rendering parameters, single- or representative-conformer input, incomplete matched benchmarking against 2D and 3D molecular representation models, and an interpretability gap addressed in part by CAM-family visualization in the AI-based Substance Hazard Integrated Prediction System (AI-SHIPS) and S-COPHY (a model developed by Shiseido for cosmetics-pharmaceutical compound classification). Future directions include standardized image-generation protocols, conformer-ensemble extensions, systematic interpretability analysis, matched benchmarking, and potential integration with graph-based and 3D-aware molecular learning approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.